MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Performance of Parkinson´s disease cognitive scale rating scale (PD-CRS) after subthalamic nucleus deep brain stimulation. Comparison with Mattis Dementia Rating Scale (MDRS) and Mini-Mental State Examination (MMSE)

    C. García-Sánchez, B. Pascual-Sedano, A. Gironell, R. Rodriguez, J. Pagonabarraga-Mora, J. Marin-Lahoz, J. Pérez-Perez, A. Campolongo, C. izquierdo, H. Bejr-Kasen, I. Aracil, S. Martínez -Horta, A. Horta, M. Botí, E. Marin, J. Kulisevsky (Barcelona, Spain)

    Objective: To study the performance of PD-CRS before and after STN-DBS and compare their results with other recognized cognitive scales. Background: Deep brain stimulation of…
  • 2018 International Congress

    Meta-Analysis of Short-afferent inhibition and Cognitive Impairment in Parkinson’s Disease

    J.F. Martin-Rodriguez, P. Mir (Seville, Spain)

    Objective: In this meta-analysis, we assess whether short-afferent inhibition (SAI) is impaired in Parkinson's disease (PD) patients as well as identify clinical variables associated to…
  • 2018 International Congress

    Evaluation of the Loneliness among the Caregivers of Parkinson Disease Dementia

    M. Gultekin, A. Ekinci (Kayseri, Turkey)

    Objective: This study examined loneliness among caregivers of individuals with Parkinson’s disease dementia(PDD). Background: Caregivers of people with PDD have loneliness and depression. Methods: The…
  • 2018 International Congress

    Computational and Biochemical analysis of lipid raft proteins: A new perspective approach to understand the progression of late onset Parkinson’s disease

    L. Thangamani, S. Piramanayagam (Coimbatore, India)

    Objective: In the current study we report mutations, particularly inPARK-7 gene and their impact on understanding the pathophysiology of Parkinson’s disease (PD); it also lays…
  • 2018 International Congress

    Evidence for dysregulation of inflammatory mechanisms involving the NF-κB complex in the living parkinsonian brain

    S. Benoit, H. Xu, R. Alexandrova, G. Kaur, B. Thiruvahindrapuram, M. Hebb (London, ON, Canada)

    Objective: Sequence RNA in cortical samples taken from living PD patients to detect significant differentially expressed genes (DEGs) and altered biological pathways when compared to…
  • 2018 International Congress

    Clinical evaluation of genetic changes of polymerase chain reaction in patients with PD at early stage

    M. Salokhiddinov (Tashkent, Uzbekistan)

    Objective: To assess the clinical feature of genetic changes in PARK1 (α-synuclein) and PARK2 with the help of PCR in patients with Parkinson’s disease and…
  • 2018 International Congress

    Gender effects on clinical features in LRRK2 G2385R carriers and non-carriers in Parkinson’s disease

    S. Cui, S. Chen (Shanghai, People’s Republic of China)

    Objective: This study was to explore gender effects within the same genetic subtype and role of leucine-rich repeat kinase 2 (LRRK2) G2385R variants within the…
  • 2018 International Congress

    Parkinson-related CHCHD2 is necessary for oligomerization of ALS/FTD-related CHCHD10

    D. Narendra, X. Huang, B. Wu, Y. Liu, D. Nguyen, M. Marani (Bethesda, MD, USA)

    Objective: Characterization of isogenic CHCHD2, CHCHD10, and CHCHD2/10 double knockout out cell lines with assays of mitochondrial function, mitochondrial sublocalization, and homo- and heterodimerization. Background:…
  • 2018 International Congress

    Cerebellar atrophy in different motor and non-motor subtypes of Parkinson’s disease

    XX. Ma, CM. Li, W. Su, HB. Chen (Beijing, China)

    Objective: The cerebellum is involved in Parkinson’s disease (PD). This study was to investigate, using MRI and voxel-based morphometry (VBM), morphometric changes of cerebellum in…
  • 2018 International Congress

    Ultrasonographic signatures associated with movement disorders (USA-MD study): A population-based longitudinal study

    A. Crespo Cuevas, L. Ispierto, E. Lopez-Cancio, A. Planas, T. Canento, M. Hernandez-Pérez, R. Alvarez, D. Vilas (Badalona, Spain)

    Objective: To identify sonographic biomarkers of PD (Parkinson´s disease). Background: Study of Parkinson’s disease biomarkers could lead us to identify the disease at its earlier…
  • « Previous Page
  • 1
  • …
  • 150
  • 151
  • 152
  • 153
  • 154
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Striatal Hand Signs” and early diagnosis of Parkinson's Disease: The “Monkey-Wrench Sign”.
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley